Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Bruce Keyt currently holds 242,948 shares of IGM Biosciences, Inc. (IGMS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bruce Keyt has been a net seller of IGMS stock. They have purchased $0 and sold $3.6M worth of shares.
Bruce Keyt's most recent insider trade was on Sep 13, 2024, when they sold 1,487 shares at $11.54 per share.
Bruce Keyt serves as Executive at IGM Biosciences, Inc. (IGMS). They have executed 99 insider transactions totaling $3.6M over their tenure at the company.
Bruce Keyt holds the position of Executive at IGM Biosciences, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 6 years and currently hold a stake valued at $0.
Bruce Keyt has shown a selling trading pattern, with $0 in total purchases and $3.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Bruce Keyt was on Oct 4, 2022, when they sold $571.0K worth of IGMS shares. This transaction involved 25,000 shares at $22.84 per share.
Bruce Keyt currently owns 242,948 shares of IGM Biosciences, Inc. (IGMS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Bruce Keyt's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Bruce Keyt has 99 Form 4 filings on record as an insider at IGM Biosciences, Inc..
Set alerts for Bruce Keyt and 40,000+ other insiders.